0001415889-23-004626.txt : 20230309
0001415889-23-004626.hdr.sgml : 20230309
20230309211807
ACCESSION NUMBER: 0001415889-23-004626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230308
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Englese Thomas
CENTRAL INDEX KEY: 0001825799
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39577
FILM NUMBER: 23721436
MAIL ADDRESS:
STREET 1: C/O AZIYO BIOLOGICS, INC.
STREET 2: 12510 PROSPERITY DRIVE, SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
FORMER NAME:
FORMER CONFORMED NAME: Englese Tom
DATE OF NAME CHANGE: 20200923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001708527
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474790334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
BUSINESS PHONE: 240-247-1143
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
4
1
form4-03102023_020301.xml
X0306
4
2023-03-08
0001708527
AZIYO BIOLOGICS, INC.
AZYO
0001825799
Englese Thomas
C/O AZIYO BIOLOGICS, INC.
12510 PROSPERITY DRIVE, SUITE 370
SILVER SPRING
MD
20904
false
true
false
false
CHIEF COMMERCIAL OFFICER
Class A Common Stock
2023-03-08
4
M
0
937
0
A
18206
D
Class A Common Stock
2023-03-09
4
S
0
289
4.30
D
17917
D
Restricted Stock Units
2023-03-08
4
M
0
937
0
D
Class A Common Stock
937
1875
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
2023-03-09